Training to Improve Dyspnoea in Chronic Obstructive Pulmonary Disease
Chief Investigator: Professor Sally Singh
Chronic obstructive pulmonary disease (COPD) is a common long term condition and is predicted by the World Health Organisation to become fifth most important cause of disability worldwide by 2020.
Dyspnoea (or breathlessness) is the most common complaint amongst patients with COPD, many of whom avoid daily physical tasks and have a reduced quality of life.
An intervention to provide dyspnoea relief has been developed to train respiratory muscles and improve secretion clearance using an airway oscillation (vibration) device. This is a novel device and has recently been developed for COPD, therefore it is important to conduct research to understand whether this device could provide dyspnoea relief and improve exercise capacity and quality of life for patients with COPD.
The TIDe study aims to investigate whether airway oscillations can demonstrably reduce breathlessness and increase exercise capacity in patients with COPD. Specifically, it will assess the effectiveness of a High-Frequency Airway Oscillation device, using a ‘sham’ or placebo device as a control. Participants in the research will be assigned to one of the two devices at random and neither they nor their healthcare professional will know which device they have been given until after the trial is completed.
The TIDe study is funded by Actegy Ltd.
Recruitment to the main TIDe study is now closed, however substudies (CORE, ExPORt and ExPRes) are ongoing:
CORE Patient Information Sheet
ExPORt Patient Information Sheet
ExPRes Patient Information Sheet
For more information contact: enya.daynes@uhl-tr.nhs.uk or 01162502758
You can read publications related to the TIDe study here and here.